BrightSpire Capital, Inc.

NYSE:BRSP Stock Report

Market Cap: US$810.5m

BrightSpire Capital Valuation

Is BRSP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BRSP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BRSP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BRSP's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BRSP?

Key metric: As BRSP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BRSP. This is calculated by dividing BRSP's market cap by their current revenue.
What is BRSP's PS Ratio?
PS Ratio2.2x
SalesUS$378.10m
Market CapUS$810.53m

Price to Sales Ratio vs Peers

How does BRSP's PS Ratio compare to its peers?

The above table shows the PS ratio for BRSP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.8x
FBRT Franklin BSP Realty Trust
6.2x9.9%US$1.1b
PMT PennyMac Mortgage Investment Trust
1.4x-27.1%US$1.1b
ARR ARMOUR Residential REIT
5.7x28.7%US$1.1b
LADR Ladder Capital
5.8x10.3%US$1.5b
BRSP BrightSpire Capital
2.2x-43.5%US$810.5m

Price-To-Sales vs Peers: BRSP is good value based on its Price-To-Sales Ratio (2.2x) compared to the peer average (4.8x).


Price to Sales Ratio vs Industry

How does BRSP's PS Ratio compare vs other companies in the US Mortgage REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
BMNM Bimini Capital Management
0.7xn/aUS$9.54m
No more companies available in this PS range
BRSP 2.2xIndustry Avg. 5.1xNo. of Companies5PS03.26.49.612.816+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BRSP is good value based on its Price-To-Sales Ratio (2.2x) compared to the US Mortgage REITs industry average (5.1x).


Price to Sales Ratio vs Fair Ratio

What is BRSP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BRSP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.2x
Fair PS Ratio1.1x

Price-To-Sales vs Fair Ratio: BRSP is expensive based on its Price-To-Sales Ratio (2.2x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BRSP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$6.29
US$7.60
+20.8%
16.7%US$10.00US$6.25n/a5
Nov ’25US$5.82
US$7.69
+32.1%
18.3%US$10.00US$6.25n/a4
Oct ’25US$5.50
US$7.50
+36.4%
21.6%US$10.00US$5.50n/a4
Sep ’25US$5.95
US$7.50
+26.1%
21.6%US$10.00US$5.50n/a4
Aug ’25US$5.65
US$7.50
+32.7%
21.6%US$10.00US$5.50n/a4
Jul ’25US$5.74
US$7.88
+37.2%
19.2%US$10.00US$6.00n/a4
Jun ’25US$6.05
US$7.88
+30.2%
19.2%US$10.00US$6.00n/a4
May ’25US$6.23
US$8.20
+31.6%
13.7%US$10.00US$6.50n/a5
Apr ’25US$6.60
US$8.20
+24.2%
13.7%US$10.00US$6.50n/a5
Mar ’25US$6.95
US$8.20
+18.0%
13.7%US$10.00US$6.50n/a5
Feb ’25US$7.23
US$8.20
+13.4%
13.7%US$10.00US$6.50n/a5
Jan ’25US$7.44
US$7.80
+4.8%
18.4%US$10.00US$6.00n/a5
Dec ’24US$6.95
US$7.80
+12.2%
18.4%US$10.00US$6.00n/a5
Nov ’24US$5.81
US$8.25
+42.0%
15.2%US$10.00US$6.50US$5.824
Oct ’24US$6.26
US$8.63
+37.8%
13.8%US$10.00US$7.00US$5.504
Sep ’24US$6.95
US$8.63
+24.1%
13.8%US$10.00US$7.00US$5.954
Aug ’24US$7.14
US$8.50
+19.0%
16.1%US$10.00US$6.50US$5.654
Jul ’24US$6.73
US$8.50
+26.3%
16.1%US$10.00US$6.50US$5.744
Jun ’24US$6.03
US$8.50
+41.0%
16.1%US$10.00US$6.50US$6.054
May ’24US$5.62
US$9.38
+66.8%
8.7%US$10.00US$8.00US$6.234
Apr ’24US$5.90
US$10.00
+69.5%
16.2%US$12.50US$8.00US$6.604
Mar ’24US$6.34
US$10.50
+65.6%
11.2%US$12.50US$9.50US$6.954
Feb ’24US$7.69
US$10.00
+30.0%
14.5%US$12.50US$8.00US$7.235
Jan ’24US$6.23
US$10.00
+60.5%
14.5%US$12.50US$8.00US$7.445
Dec ’23US$7.12
US$10.00
+40.4%
14.5%US$12.50US$8.00US$6.955
Nov ’23US$7.74
US$10.60
+37.0%
12.8%US$12.50US$8.50US$5.815

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies